M9466
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for M9466, covering 2025-06-17 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501) [Phase 1]